Infantile hemangiomas (IH) are benign, proliferative, vascular tumour involving the vascular endothelium. It is the most common tumour of infancy, present in 5 % of newborns.Prematurity, LBW, Female sex, white race are known risk factors. IHs more commonly present at first two weeks of life or at birth. Most IHs enlarges in size and spontaneously involute. Expectant observation and reassurance of the parents is recommended. Topical Timolol 0.5 % gel, Oral Propranolol and Oral and intralesional Corticosteroids, pulsed dye laser therapy, or surgical excision is the recommended treatment options available. Complications like ulceration, secondary Infection; permanent disfigurement can result from an Infantile Hemangioma.